Journal articles on the topic 'Pharmaceutical biotechnology – Law and legislation'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pharmaceutical biotechnology – Law and legislation.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Omelchenko, Olha. "Some aspects of the intellectual property legislation development to expand access to biotechnology medicines." Theory and Practice of Intellectual Property, no. 1 (March 18, 2025): 97–104. https://doi.org/10.33731/12025.325004.
Full textDel CASTILLO Rodríguez, Carlos. "PHARMACEUTICAL LEGISLATION OR PHARMACEUTICAL LAW? ANALYSIS." Vitae 18, no. 1 (2011): 83–87. http://dx.doi.org/10.17533/udea.vitae.8771.
Full textIvanenko, Dmytro, and Nataliia Hlushchenko. "LEGAL ASPECTS OF INTELLECTUAL PROPERTY IMPACT ON AVAILABILITY OF MEDICINES IN UKRAINE." Law Journal of Donbass 76, no. 3 (2021): 39–44. http://dx.doi.org/10.32366/2523-4269-2021-76-3-39-44.
Full textOmelchenko, Olha. "Intellectual property rights in the context of biology, medicine and pharmacy: a look into the future." Theory and Practice of Intellectual Property, no. 3 (June 19, 2023): 109–17. http://dx.doi.org/10.33731/32023.282330.
Full textHolman, Christopher M. "Congress Considering Legislation Aimed at Increasing Competition in Pharmaceuticals." Biotechnology Law Report 38, no. 3 (2019): 144–53. http://dx.doi.org/10.1089/blr.2019.29125.cmh.
Full textAlbolino, Sara, Tommaso Bellandi, Simone Cappelletti, et al. "New Rules on Patient’s Safety and Professional Liability for the Italian Health Service." Current Pharmaceutical Biotechnology 20, no. 8 (2019): 615–24. http://dx.doi.org/10.2174/1389201020666190408094016.
Full textSEREBRENNIKOVA, ANNA. "PHARMACEUTICAL LAW: CRIMINAL ASPECTS." Gaps in Russian Legislation 14, no. 6 (2021): 203–9. http://dx.doi.org/10.33693/2072-3164-2021-14-6-203-209.
Full textFrolova, O. "Implementation of EU legislation into the criminal legislation of Ukraine to ensure criminal legal protection of pharmaceutical activity." Scientific and informational bulletin of Ivano-Frankivsk University of Law named after King Danylo Halytskyi, no. 16(28) (December 13, 2023): 176–83. http://dx.doi.org/10.33098/2078-6670.2023.16.28.176-183.
Full textMalinowski, Michael J. "Pharmaceutical Medicine, Biotechnology and European Law." Journal of Legal Medicine 23, no. 1 (2002): 159–66. http://dx.doi.org/10.1080/019476402317276722.
Full textNoguera Peña, Alfonso, and Carlos del Castillo Rodríguez. "Pharmaceutical Law and Pharmaceutical Legislation in Spain and in the European Union: Concept, Evolution and Sources." Anales de la Real Academia Nacional de Farmacia 87, no. 87(03) (2021): 275–322. http://dx.doi.org/10.53519/analesranf.2021.87.03.06.
Full textFrolova, O. G. "Criminal legal protection of pharmaceutical activity on the circulation of medicinal products in acts of foreign criminal legislation." Analytical and Comparative Jurisprudence, no. 5 (November 17, 2023): 495–501. http://dx.doi.org/10.24144/2788-6018.2023.05.89.
Full textYurkovska, Lidiia H., Volodymyr V. Krasnov, and Serhii H. Ubohov. "QUALITY ASSURANCE OF MEDICINES: THE STATE AND TRENDS OF THE EUROPEAN UNION AND UKRAINE LEGISLATION DEVELOPMENT." Wiadomości Lekarskie 74, no. 1 (2021): 150–54. http://dx.doi.org/10.36740/wlek202101129.
Full textAleksieiev, O. H. "Grounds for legal liability in the pharmaceutical sector of the healthcare sector." Zaporozhye Medical Journal 23, no. 2 (2021): 280–85. http://dx.doi.org/10.14739/2310-1210.2021.2.228794.
Full textvan Wyk, Christa. "Book Review: Pharmaceutical Medicine, Biotechnology, and European Law." Maastricht Journal of European and Comparative Law 8, no. 4 (2001): 397–405. http://dx.doi.org/10.1177/1023263x0100800404.
Full textHarris, Rebecca C. "State responses to biotechnology." Politics and the Life Sciences 34, no. 1 (2015): 1–27. http://dx.doi.org/10.1017/pls.2015.2.
Full textBrosch, Sabine, and Alessandro Spina. "International Conference on Harmonisation and Standardisation Initiatives in the Pharmaceutical Domain." European Journal of Risk Regulation 1, no. 3 (2010): 274–76. http://dx.doi.org/10.1017/s1867299x00000477.
Full textFirman Erry Probo, Anis Widyawati, and Duhita Driyah Suprapti. "CRIMINAL LAW POLICY OF ILLEGAL PHARMACEUTICAL PREPARATIONS IN THE HEALTH OMNIBUS LAW." MORFAI JOURNAL 4, no. 4 (2025): 1566–71. https://doi.org/10.54443/morfai.v4i4.2428.
Full textDrigo, A. E., L. I. Lavrenteva, O. V. Zheltkevich, and N. V. Korchkova. "Topical issues of pharmaceutical organization systematization." Remedium Journal about the Russian market of medicines and medical equipment, no. 11-12 (2020): 55–60. http://dx.doi.org/10.21518/1561-5936-2020-11-12-55-60.
Full textVarela, Justo Corti. "Biotechnology." European Journal of Risk Regulation 1, no. 1 (2010): 63–71. http://dx.doi.org/10.1017/s1867299x00000076.
Full textLentz, Edward T. "Pharmaceutical and Biotechnology Research Revisited." Biotechnology Law Report 25, no. 1 (2006): 2–5. http://dx.doi.org/10.1089/blr.2006.25.2.
Full textFrolova, Olena. "CAUSING HARM TO PHARMACEUTICAL ACTIVITY AS AN OBJECT OF CRIMINAL LAW PROTECTION." Scientific Journal of Polonia University 62, no. 1 (2024): 151–57. http://dx.doi.org/10.23856/6220.
Full textMorozova, Natalya Arkadyevna. "Issues of interaction and cooperation between prescribers and pharmaceutical companies." Ophthalmology journal 6, no. 3 (2013): 4–8. http://dx.doi.org/10.17816/ov201334-8.
Full textAleksieiev, O. H. "Conceptual and category apparatus of legislation, what determines legal responsibility in pharmaceutical activity." Current issues in pharmacy and medicine: science and practice 15, no. 2 (2022): 201–7. http://dx.doi.org/10.14739/2409-2932.2022.2.255817.
Full textOlzhabayeva, X. B. "Analysis of Kazakhstan legislation regulating the labour of medical and pharmaceutical workers." BULLETIN of L.N. Gumilyov Eurasian National University. Law Series 137, no. 4 (2021): 132–41. http://dx.doi.org/10.32523/2616-6844-2021-137-4-132-141.
Full textGuţiu, Simona. "Some considerations of Romanian legal framework on online sale of OTC medicine. Coordination or contradiction to European legislation?" Proceedings of the International Conference on Business Excellence 15, no. 1 (2021): 930–35. http://dx.doi.org/10.2478/picbe-2021-0086.
Full textPashkov, V. M. "LEGAL REGULATION OF MOST DANGEROUS MICROORGANISMS STRAINS HANDLING." Medicne pravo, no. 2(28) (October 7, 2021): 71–79. http://dx.doi.org/10.25040/medicallaw2021.02.071.
Full textSpina, Alessandro. "Pharmaceuticals." European Journal of Risk Regulation 1, no. 1 (2010): 81–82. http://dx.doi.org/10.1017/s1867299x00000106.
Full textJablonski, Tomasz. "End of the Transitional Period for Traditional Herbal Medicinal Products Coming Soon." European Journal of Risk Regulation 1, no. 2 (2010): 156–59. http://dx.doi.org/10.1017/s1867299x0000026x.
Full textBombillar, Francisco. "The Case of Pandemic Flu Vaccines: Some Lessons Learned." European Journal of Risk Regulation 1, no. 4 (2010): 427–31. http://dx.doi.org/10.1017/s1867299x00000908.
Full textKiedrzynek, Michał. "Ewolucja administracji farmaceutycznej w Polsce." Studenckie Prace Prawnicze, Administratywistyczne i Ekonomiczne 20 (September 20, 2017): 65–76. http://dx.doi.org/10.19195/1733-5779.20.5.
Full textPirtskhalava, Kh D. "Ethical Standards in Innovative Medicine." Courier of Kutafin Moscow State Law University (MSAL)), no. 9 (December 21, 2023): 182–87. http://dx.doi.org/10.17803/2311-5998.2023.109.9.182-187.
Full textKondrat'ev, V. A. "Consumerism Qualification: Doctrine and Case Law." Rossijskoe pravosudie 5 (May 25, 2021): 22–28. http://dx.doi.org/10.37399/issn2072-909x.2021.5.22-28.
Full textFaltus, Timo. "The Medicinal Phage—Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation." Viruses 16, no. 3 (2024): 443. http://dx.doi.org/10.3390/v16030443.
Full textZhang, Jing, Shuchen Tang, and Pengqing Sun. "From Command-Control to Lifecycle Regulation: Balancing Innovation and Safety in China’s Pharmaceutical Legislation." Healthcare 13, no. 6 (2025): 588. https://doi.org/10.3390/healthcare13060588.
Full textShapovalov, Valerii. "Судова фармація, організація фармацевтичної справи, технологія ліків, медичне, фармацевтичне та кримінальне право: державна система боротьби із незаконним обігом наркотичних засобів і психотропних речовин та зловживання ними в умовах пандемії". SSP Modern Law and Practice 2, № 3 (2022): 1–35. http://dx.doi.org/10.53933/sspmlp.v2i3.66.
Full textSdvizhkov, M. А. "Antitrust Compliance in the Pharmaceutical Industry: Problems and Prospects of Implementation." Russian competition law and economy, no. 4 (January 12, 2022): 52–59. http://dx.doi.org/10.47361/2542-0259-2021-4-28-52-59.
Full textManak, Joseph M. "The Law of Written Description in Pharmaceutical and Biotechnology Patents." Biotechnology Law Report 23, no. 1 (2004): 30–47. http://dx.doi.org/10.1089/073003104322838231.
Full textKhassenov, M. K. "Some issues of labor regulation of medical and pharmaceutical workers in selected OECD countries." BULLETIN of L.N. Gumilyov Eurasian National University. Law Series 137, no. 4 (2021): 98–109. http://dx.doi.org/10.32523/2616-6844-2021-137-4-98-109.
Full textMokhov, A. A. "The Concept of Four "Bio" in Law and Legislation." Actual Problems of Russian Law 15, no. 8 (2020): 146–54. http://dx.doi.org/10.17803/1994-1471.2020.117.8.146-154.
Full textLisman, John A., and J. Frits F. Lekkerkerker. "Four decades of European medicines regulation: What have they brought us?" International Journal of Risk & Safety in Medicine 17, no. 1-2 (2005): 73–79. https://doi.org/10.3233/jrs-2005-337.
Full textFernando, Andrian, and Tri Susilowati. "Legislative Functions of the House of Representatives in the Perspective of the 1945 Constitution of the Republic of Indonesia." Jurnal Indonesia Sosial Sains 4, no. 06 (2023): 523–30. http://dx.doi.org/10.59141/jiss.v4i06.828.
Full textAleksieiev, O. H. "Conceptual and terminological apparatus for disciplinary responsibility in pharmaceutical activity." Current issues in pharmacy and medicine: science and practice 16, no. 2 (2023): 181–85. http://dx.doi.org/10.14739/2409-2932.2023.2.277085.
Full textVakhonieva, T. "LEGAL STATUS AND QUALIFICATION REQUIREMENTS FOR PHARMACEUTICAL WORKERS." Bulletin of Taras Shevchenko National University of Kyiv. Legal Studies, no. 116 (2021): 11–14. http://dx.doi.org/10.17721/1728-2195/2021/1.116-2.
Full textХабриева, Талия, and Taliya Khabriyeva. "Main Vectors and Problems of Development of Social Legislation." Journal of Russian Law 2, no. 8 (2014): 5–15. http://dx.doi.org/10.12737/5271.
Full textPrepyalov, Alexander V. "A medicine as an object of civil rights: A concept, attributes and comparison to the foreign approach." Vestnik of Saint Petersburg University. Law 13, no. 4 (2022): 1058–77. http://dx.doi.org/10.21638/spbu14.2022.414.
Full textKrasnianska, Tetiana, and Mykola Ponomarenko. "Organization of the Pharmaceutical Business, Drug Technology and Forensic Pharmacy: Modern Trends in The Development of the Science of Pharmaceutical Law During the Covid-19 Pandemic." SSP Modern Pharmacy and Medicine 2, no. 3 (2022): 1–15. http://dx.doi.org/10.53933/sspmpm.v2i3.59.
Full textLiikanen, Erkki. "Changes to the European Union pharmaceutical legislation: Implications of the ‘Pharma Review’ for biotechnology companies." Journal of Commercial Biotechnology 11, no. 1 (2004): 38–43. http://dx.doi.org/10.1057/palgrave.jcb.3040099.
Full textK. A., Krasnova. "Crime in Esports – Criminal Law Considerations." Rossijskoe pravosudie, no. 10 (September 27, 2021): 90–97. http://dx.doi.org/10.37399/issn2072-909x.2021.10.90-97.
Full textBeletsky, Leo. "21st Century Cures for the Opioid Crisis: Promise, Impact, and Missed Opportunities." American Journal of Law & Medicine 44, no. 2-3 (2018): 359–85. http://dx.doi.org/10.1177/0098858818789417.
Full textBerzin, P., R. Volynets, and O. Frolova. "Atypical features of the Austrian model of criminal law protection of circulation of medical devices." Uzhhorod National University Herald. Series: Law 2, no. 80 (2024): 16–22. http://dx.doi.org/10.24144/2307-3322.2023.80.2.2.
Full text